GLAXOSMITHKLINE PHARMACEUTICALS LTD SCREENER.

IN

Narration Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24 Trailing Best Case Worst Case
Sales 3,304.52 2,837.91 2,908.47 2,871.46 3,128.12 3,224.38 2,925.60 3,278.03 3,251.72 3,453.71 3,506.70 3,668.25 3,470.96
Expenses 2,671.55 2,359.63 2,488.75 2,363.23 2,527.32 2,567.13 2,327.40 2,516.15 2,447.44 2,545.02 2,511.35 2,627.04 2,761.90
Operating Profit 632.97 478.28 419.72 508.23 600.80 657.25 598.20 761.88 804.28 908.69 995.35 1,041.20 709.05
Other Income 148.53 125.48 118.80 69.91 131.01 -262.48 8.80 1,401.30 102.74 -21.02 -39.12 - -
Depreciation 25.35 24.95 27.08 37.99 48.59 82.68 78.60 68.19 65.77 69.68 69.73 69.73 69.73
Interest 0.47 0.42 0.25 0.19 0.55 6.34 3.53 2.00 1.81 1.80 1.89 1.89 1.89
Profit before tax 755.68 578.39 511.19 539.96 682.67 305.75 524.87 2,092.99 839.44 816.19 884.61 969.58 637.43
Tax 279.27 202.25 174.38 189.24 237.27 212.55 166.72 398.28 228.76 226.23 244.57 28% 28%
Net profit 476.41 376.14 336.81 350.73 445.39 93.20 358.15 1,694.72 610.69 589.96 640.04 701.52 461.20
EPS 28.12 22.20 19.88 20.70 26.29 5.50 21.14 100.04 36.05 34.83 37.80 41.43 27.24
Price to earning 60.90 85.90 69.02 50.42 49.35 228.54 68.15 16.66 36.75 55.89 73.85 73.85 45.79
Price 1,712.83 1,907.38 1,372.28 1,043.88 1,297.45 1,257.40 1,440.75 1,666.90 1,324.75 1,946.60 2,791.30 3,059.43 1,247.07

RATIOS:
Dividend Payout 111.12% 112.59% 75.44% 84.52% 76.07% 727.08% 141.90% 89.97% 88.77% 91.89%
OPM 19.15% 16.85% 14.43% 17.70% 19.21% 20.38% 20.45% 23.24% 24.73% 26.31% 28.38%

TRENDS: 10 YEARS 7 YEARS 5 YEARS 3 YEARS RECENT BEST WORST

Sales Growth 0.49% 2.48% 2.00% 5.69% 6.21% 6.21% 0.49%
OPM 20.43% 21.86% 23.12% 24.79% 28.38% 28.38% 20.43%
Price to Earning 72.31 72.45 79.97 45.79 73.85 73.85 45.79
GLAXOSMITHKLINE PHARMACEUTICALS LTD SCREENER.IN

Narration Mar-22 Jun-22 Sep-22 Dec-22 Mar-23 Jun-23 Sep-23 Dec-23 Mar-24 Jun-24
Sales 809.63 745.10 916.87 802.30 787.45 761.66 956.99 805.26 929.80 814.65
Expenses 634.41 596.18 659.94 573.60 617.71 617.78 667.50 587.20 672.54 584.11
Operating Profit 175.22 148.92 256.93 228.70 169.74 143.88 289.49 218.06 257.26 230.54
Other Income 1,321.97 30.66 21.97 12.05 38.06 53.74 28.21 -135.20 32.23 35.64
Depreciation 15.35 15.82 16.36 16.41 17.18 16.36 18.11 17.11 18.10 16.41
Interest 0.28 0.68 0.39 0.09 0.65 0.28 0.43 0.32 0.77 0.37
Profit before tax 1,481.56 163.08 262.15 224.25 189.97 180.98 299.16 65.43 270.62 249.40
Tax 262.51 43.80 68.73 59.69 56.54 48.73 81.65 19.71 76.14 67.07
Net profit 1,219.05 119.28 193.42 164.56 133.43 132.25 217.51 45.72 194.48 182.33

OPM 22% 20% 28% 29% 22% 19% 30% 27% 28% 28%
GLAXOSMITHKLINE PHARMACEUTICALS LTD SCREENER.IN

Narration Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24
Equity Share Capital 84.70 84.70 84.70 84.70 169.41 169.41 169.41 169.41 169.41 169.41
Reserves 1,744.28 2,098.55 1,922.15 1,972.63 1,970.42 1,651.20 1,308.85 2,493.55 1,571.87 1,608.23
Borrowings 3.12 2.37 1.60 0.99 0.58 0.18 34.63 20.08 15.54 18.67
Other Liabilities 1,383.57 869.26 995.39 1,889.17 1,770.90 1,312.45 1,601.75 1,950.23 1,569.76 1,760.31
Total 3,215.67 3,054.88 3,003.84 3,947.49 3,911.31 3,133.24 3,114.64 4,633.27 3,326.58 3,556.62

Net Block 123.08 204.04 258.05 324.59 431.63 758.08 386.91 330.65 329.96 321.27
Capital Work in Progress 115.22 267.67 605.46 922.90 1,002.64 120.12 13.21 30.50 20.31 13.93
Investments 0.06 6.04 0.06 0.06 0.06 - - 365.59 518.29 813.22
Other Assets 2,977.31 2,577.13 2,140.27 2,699.94 2,476.98 2,255.04 2,714.52 3,906.53 2,458.02 2,408.20
Total 3,215.67 3,054.88 3,003.84 3,947.49 3,911.31 3,133.24 3,114.64 4,633.27 3,326.58 3,556.62

Working Capital 1,593.74 1,707.87 1,144.88 810.77 706.08 942.59 1,112.77 1,956.30 888.26 647.89
Debtors 100.32 126.57 170.80 146.96 120.49 99.80 215.60 205.24 192.38 222.06
Inventory 375.58 525.87 425.80 500.18 486.49 483.03 546.70 534.70 459.97 525.05

Debtor Days 11.08 16.28 21.43 18.68 14.06 11.30 26.90 22.85 21.59 23.47
Inventory Turnover 8.80 5.40 6.83 5.74 6.43 6.68 5.35 6.13 7.07 6.58

Return on Equity 26% 17% 17% 17% 21% 5% 24% 64% 35% 33%
Return on Capital Emp 29% 24% 27% 33% 16% 32% 100% 38% 46%
GLAXOSMITHKLINE PHARMACEUTICALS LTD SCREENER.IN

Narration Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24
Cash from Operating Activity 337.64 138.90 234.37 472.80 409.49 490.50 577.91 810.75 484.23 582.02
Cash from Investing Activity 180.01 499.02 300.64 -104.19 -153.45 -56.84 418.03 -405.51 807.85 8.71
Cash from Financing Activity -496.99 -638.33 -510.76 -306.63 -358.36 -427.62 -695.56 -524.24 -1,543.32 -561.50
Net Cash Flow 20.66 -0.42 24.24 61.97 -102.33 6.03 300.38 -119.00 -251.25 29.23
How to use it?
You can customize this workbook as you want.
You can add custom formating, add conditional formating, add your own formulas… do ANYTHING.
Please don't edit the "Data Sheet" only.

After customization, you can upload this back on Screener.

Upload on: https://www.screener.in/excel/

Download your customized workbooks now onwards.

Now whenever you will "Export to excel" from Screener, it will export your customized file.

TESTING:
This is a testing feature currently.
You can report any formula errors on the worksheet at: [email protected]
s… do ANYTHING.
COMPANY NAME GLAXOSMITHKLINE PHARMACEUTICALS LTD
LATEST VERSION 2.10 PLEAS
CURRENT VERSION 2.10

META
Number of shares 16.93
Face Value 10.00
Current Price 2,791.30
Market Capitalization 47,267.72

PROFIT & LOSS

Report Date Mar-15 Mar-16 Mar-17 Mar-18
Sales 3,304.52 2,837.91 2,908.47 2,871.46
Raw Material Cost 1,514.14 1,377.57 1,314.38 1,299.24
Change in Inventory 3.70 144.48 -83.37 57.93
Power and Fuel 31.17 25.97 27.82 26.44
Other Mfr. Exp 126.06 209.90 108.26 110.55
Employee Cost 493.81 444.41 484.34 524.79
Selling and admin 445.98 332.59 372.66 357.45
Other Expenses 64.09 113.67 97.92 102.69
Other Income 148.53 125.48 118.80 69.91
Depreciation 25.35 24.95 27.08 37.99
Interest 0.47 0.42 0.25 0.19
Profit before tax 755.68 578.39 511.19 539.96
Tax 279.27 202.25 174.38 189.24
Net profit 476.41 376.14 336.81 350.73
Dividend Amount 529.38 423.50 254.10 296.45

Quarters
Report Date Mar-22 Jun-22 Sep-22 Dec-22
Sales 809.63 745.10 916.87 802.30
Expenses 634.41 596.18 659.94 573.60
Other Income 1,321.97 30.66 21.97 12.05
Depreciation 15.35 15.82 16.36 16.41
Interest 0.28 0.68 0.39 0.09
Profit before tax 1,481.56 163.08 262.15 224.25
Tax 262.51 43.80 68.73 59.69
Net profit 1,219.05 119.28 193.42 164.56
Operating Profit 175.22 148.92 256.93 228.70

BALANCE SHEET
Report Date Mar-15 Mar-16 Mar-17 Mar-18
Equity Share Capital 84.70 84.70 84.70 84.70
Reserves 1,744.28 2,098.55 1,922.15 1,972.63
Borrowings 3.12 2.37 1.60 0.99
Other Liabilities 1,383.57 869.26 995.39 1,889.17
Total 3,215.67 3,054.88 3,003.84 3,947.49
Net Block 123.08 204.04 258.05 324.59
Capital Work in Progress 115.22 267.67 605.46 922.90
Investments 0.06 6.04 0.06 0.06
Other Assets 2,977.31 2,577.13 2,140.27 2,699.94
Total 3,215.67 3,054.88 3,003.84 3,947.49
Receivables 100.32 126.57 170.80 146.96
Inventory 375.58 525.87 425.80 500.18
Cash & Bank 1,910.61 1,391.90 899.61 1,296.41
No. of Equity Shares 84,703,017.00 84,703,017.00 84,703,017.00 84,703,017.00
New Bonus Shares
Face value 10.00 10.00 10.00 10.00

CASH FLOW:
Report Date Mar-15 Mar-16 Mar-17 Mar-18
Cash from Operating Activity 337.64 138.90 234.37 472.80
Cash from Investing Activity 180.01 499.02 300.64 -104.19
Cash from Financing Activity -496.99 -638.33 -510.76 -306.63
Net Cash Flow 20.66 -0.42 24.24 61.97

PRICE: 1,712.83 1,907.38 1,372.28 1,043.88

DERIVED:
Adjusted Equity Shares in Cr 16.94 16.94 16.94 16.94
 PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET

Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24

3,128.12 3,224.38 2,925.60 3,278.03 3,251.72 3,453.71
1,332.46 1,343.30 1,294.88 1,340.62 1,215.92 1,398.25
-25.57 35.43 38.02 -15.57 -68.96 63.72
27.94 33.36 26.08 27.83 29.60 29.64
115.55 107.89 110.59 120.14 99.05 113.61
539.28 629.85 618.08 611.66 596.74 626.04
379.33 375.58 240.13 342.24 368.55 373.08
107.19 112.58 75.66 58.09 68.62 68.12
131.01 -262.48 8.80 1,401.30 102.74 -21.02
48.59 82.68 78.60 68.19 65.77 69.68
0.55 6.34 3.53 2.00 1.81 1.80
682.67 305.75 524.87 2,092.99 839.44 816.19
237.27 212.55 166.72 398.28 228.76 226.23
445.39 93.20 358.15 1,694.72 610.69 589.96
338.82 677.64 508.23 1,524.69 542.11 542.11

Mar-23 Jun-23 Sep-23 Dec-23 Mar-24 Jun-24

787.45 761.66 956.99 805.26 929.80 814.65
617.71 617.78 667.50 587.20 672.54 584.11
38.06 53.74 28.21 -135.20 32.23 35.64
17.18 16.36 18.11 17.11 18.10 16.41
0.65 0.28 0.43 0.32 0.77 0.37
189.97 180.98 299.16 65.43 270.62 249.40
56.54 48.73 81.65 19.71 76.14 67.07
 133.43 132.25 217.51 45.72 194.48 182.33
169.74 143.88 289.49 218.06 257.26 230.54

Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24

169.41 169.41 169.41 169.41 169.41 169.41
1,970.42 1,651.20 1,308.85 2,493.55 1,571.87 1,608.23
0.58 0.18 34.63 20.08 15.54 18.67
1,770.90 1,312.45 1,601.75 1,950.23 1,569.76 1,760.31
3,911.31 3,133.24 3,114.64 4,633.27 3,326.58 3,556.62
431.63 758.08 386.91 330.65 329.96 321.27
1,002.64 120.12 13.21 30.50 20.31 13.93
0.06 365.59 518.29 813.22
2,476.98 2,255.04 2,714.52 3,906.53 2,458.02 2,408.20
3,911.31 3,133.24 3,114.64 4,633.27 3,326.58 3,556.62
120.49 99.80 215.60 205.24 192.38 222.06
486.49 483.03 546.70 534.70 459.97 525.05
1,171.35 1,083.20 1,157.96 2,484.51 1,155.93 1,063.22
### ### ### ### ### ###
84,703,017.00
10.00 10.00 10.00 10.00 10.00 10.00

Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24

409.49 490.50 577.91 810.75 484.23 582.02
-153.45 -56.84 418.03 -405.51 807.85 8.71
-358.36 -427.62 -695.56 -524.24 -1,543.32 -561.50
-102.33 6.03 300.38 -119.00 -251.25 29.23

1,297.45 1,257.40 1,440.75 1,666.90 1,324.75 1,946.60

16.94 16.94 16.94 16.94 16.94 16.94